readthroughSign in
CompanySEPNNasdaqSouth San Francisco, CA

Septerna, Inc.

Septerna develops oral small molecule GPCR modulators for endocrinology, immunology, inflammation, and metabolic diseases using its Native Complex Platform.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 9Latest story